This research provides fresh insights into strategies that can be used to improve the lives of adolescents in sub-Saharan Africa and around the world.
Rigor académico, oficio periodístico
Artículos sobre HIV
Mostrando 81 - 100 de 375 artículos
Narrow, unimaginative public health responses inhibit reducing HIV, exploitation and marginalisation within sex work.
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
New research highlights how the press excluded, shamed and invaded the privacy of those living with HIV.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
COVID-19 restrictions created life-threatening challenges to female sex workers as they weren’t able to access their medication, support or their clients.
Local and national governments in west and central African countries must prioritise investment in providing access to HIV testing for all pregnant women.
The evidence shows that keeping girls in school not only reduces HIV risk, but also delays marriage and pregnancy, and improves mental health.
In both countries, neglect and misinformation at the highest levels of government led to undue tragedy.
Parents have the primary role of educating their children about their sexuality. But cultural beliefs and taboos about sex can work strongly against their efforts.
The HIV/AIDS response played out over a much longer trajectory than COVID-19. But it is, in some respects, a shining example of what can be achieved when countries and people work together.
If the world is single-minded and focuses purely on combating one pandemic, forgetting others, the effects of other morbidity and mortality on healthcare systems will be seen for a long time to come.
Nurses represent 50% of the global healthcare workforce. And they are often the sole healthcare providers in many low and middle-income countries.
Care for patients with more than one disease is fragmented and uncoordinated. This is can cost patients time, effort and lost wages.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
Our findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.
To better anticipate and manage the emergence of new pandemics, a paradigm shift is needed to take into account the complex interactions between human health, animal health, the environment and the economy.
Equipping parents with the right information on what to talk about, and how to talk about it, is a key step in addressing challenges to sexual health.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Principales colaboradores
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor and Principal Research Fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University
-
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Senior Research Fellow, Kirby Institute, UNSW Sydney
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Associate Professor, Monash University
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Research Scientist, African Population and Health Research Center
-
Scientia Professor of Medicine and Director, Kirby Institute, UNSW Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Assistant Professor of Nursing, Case Western Reserve University
-
Associate Professor and Head of the Surveillance and Evaluation Program for Public Health at the Kirby Institute, UNSW Sydney
-
Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand
-
Professor and Director of the Centre for Social Research in Health, UNSW Sydney
